Study title: DTIC (NSC-45388) and combination therapy for melanoma. I Studies with DTIC , BCNU (NSC 409962), CCNU (NSC-79037), Vincristine (NSC67-574), and Hydroxyurea (NSC-32065). Cancer Treat Rep. 60:601-609 - Carter - 1976 - Publication in the clinical expert report from G. Mathé - 06/1975
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Neoplasms [C04] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: DACARBAZINE | |||||
ATC code: L01AX04 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |